LRRK2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis

Jessica Pei,Nathalia Luisa Oliveira,Sherilyn Junelle Recinto,Alexandra Kazanova,Celso Martins Queiroz-Junior,Ziyi Li,Katalina Couto,Susan Westfall,Irah L King,Camila Tiefense Ribeiro,Austen Milnerwood,Michel Desjardins,Ajitha Thanabalasuriar,Jo Anne STRATTON,Samantha Gruenheid
DOI: https://doi.org/10.1101/2024.11.26.625468
2024-12-02
Abstract:Parkinson Disease (PD) is a progressive, neurodegenerative disorder characterised by motor and non-motor symptoms. Emerging evidence suggests a link between PD and gastrointestinal dysfunction. Constipation is frequently observed years prior to development of motor dysfunction in PD, and people with inflammatory bowel disease (IBD) are more likely to develop PD. Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) account for approximately 1% of all PD cases and are associated with increased risk for IBD. Among them, LRRK2 Gly2019Ser (G2019S), located within the kinase domain, is the most common PD-associated mutation and increases kinase activity. It is unknown how LRRK2 mutation affects susceptibility to intestinal inflammation or pathogenesis of PD. Using single cell RNA sequencing (scRNAseq), we demonstrate that LRRK2 G2019S mutation promotes a dysregulated gene profile, especially within neutrophil, monocyte and gd T cell populations, following Citrobacter rodentium infection in mice. Transcriptionally, LRRK2 G2019S neutrophils have a greater pro-inflammatory type I and II IFN response compared to those of WT mice. This is accompanied by an increase in neutrophil numbers in the lamina propria in LRRK2 G2019S mice. We also uncover cell-intrinsic functional defects in LRRK2 G2019S neutrophils, including increased chemotaxis, degranulation and neutrophil extracellular traps (NETosis) formation. Increased neutrophil infiltration is associated with an upregulation in Th17 immune responses, which may together contribute to the observed increase in colon pathology during infection. These findings increase our understanding of the role of PD-associated genes in immune cells and their contribution to immune dysregulation. Understanding the early perturbations driven by the LRRK2 G2019S mutation in gastrointestinal pathology may facilitate the development of biomarkers for early diagnosis and intervention in PD.
Immunology
What problem does this paper attempt to address?
This paper aims to explore how the LRRK2 G2019S mutation affects intestinal inflammation and the immune response to infection. Specifically, the researchers used a mouse model carrying the LRRK2 G2019S mutation and analyzed the compositional changes and functional characteristics of immune cells in the intestinal lamina propria of these mice after infection with Citrobacter rodentium through techniques such as single - cell RNA sequencing (scRNAseq) and flow cytometry. The main research questions include: 1. **Does the LRRK2 G2019S mutation affect the colonization or clearance of Citrobacter rodentium?** The researchers evaluated the bacterial load in mice carrying the LRRK2 G2019S mutation and wild - type mice after infection with Citrobacter rodentium to determine whether the mutation affects the process of pathogen colonization or clearance. 2. **How does the LRRK2 G2019S mutation change the intestinal inflammatory response?** By analyzing indicators such as body weight change, fecal output, and fecal water content after mouse infection, the researchers explored the impact of the LRRK2 G2019S mutation on intestinal inflammation. 3. **The impact of the LRRK2 G2019S mutation on immune cells** Using single - cell RNA sequencing technology, the researchers analyzed in detail the transcriptome changes of different immune cell populations in the intestinal lamina propria of LRRK2 G2019S - mutated mice before and after infection, especially the functional differences of neutrophils, monocytes, and γδ T cells. 4. **Functional changes of neutrophils in the context of the LRRK2 G2019S mutation** The study further delved into the cellular level and evaluated the migration ability, degranulation ability, and the ability to form neutrophil extracellular traps (NETosis) of LRRK2 G2019S - mutated neutrophils through in vitro experiments. Through the above research, the authors hope to reveal the mechanism of action of the LRRK2 G2019S mutation in intestinal inflammation and how this mutation may be involved in the pathogenesis of Parkinson's disease (PD) by affecting the function of immune cells. These findings are helpful for understanding the role of PD - related genes in immune cells and their contribution to immune dysregulation, thus providing a new perspective for the early diagnosis and intervention of PD.